Document is current
Any future updates will be listed below
-
Authors
Pelletier, Simon J.
Leclercq, Mickaël
Roux-Dalvai, Florence https://orcid.org/0000-0002-9961-8964
de Geus, Matthijs B. https://orcid.org/0000-0003-1615-9393
Leslie, Shannon
Wang, Weiwei
Lam, TuKiet T. https://orcid.org/0000-0002-4850-3462
Nairn, Angus C. https://orcid.org/0000-0002-7075-0195
Arnold, Steven E.
Carlyle, Becky C. https://orcid.org/0000-0003-1491-3217
Precioso, Frédéric
Droit, Arnaud https://orcid.org/0000-0001-7922-790X
- License Information
-
More Information
Article History
Received: 28 June 2023
Accepted: 24 April 2024
First Online: 6 May 2024
Competing interests
: S. Arnold has received honoraria and/or travel expenses for lectures from Abbvie, Eisai, and Biogen and has served on scientific advisory boards of Corte, has received consulting fees from Athira, Cassava, Cognito Therapeutics, EIP Pharma and Orthogonal Neuroscience, and has received research grant support from NIH, Alzheimer’s Association, Alzheimer’s Drug Discovery Foundation, Abbvie, Amylyx, EIP Pharma, Merck, Janssen/Johnson & Johnson, Novartis, and vTv. S.N. Leslie is a current employee of Janssen Pharmaceuticals. B. Carlyle has received grant funding from Ono Pharmaceutical. Other authors report no conflicts of interest.
